Current Report Filing (8-k)
August 14 2017 - 6:10AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 7, 2017
MEDICAL
INNOVATION HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Colorado
|
|
000-27211
|
|
84-1469319
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
5805
State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address
of Principal Executive Offices) (Zip Code)
(866)
883-3793
(Registrant’s
telephone number, including area code)
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
SECTION
1 — REGISTRANT’S BUSINESS AND OPERATIONS
ITEM
1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On
August 7, 2017 Medical Innovation Holdings, Inc. (“MIHI”), a Colorado corporation (the “Company”) entered
into a Letter of Intent (LOI) with Orange Care Group of Miami lakes Florida. Medical Innovation Holdings, Inc. is to provide Information
Technology management services to practices enrolled in Orange Care Group’s Accountable Care Organizations, including Total
Care ACO, LLC d/b/a Orange Accountable Care of New York, Orange Accountable Care of New Jersey, LLC, Orange Accountable Care of
Texas, LLC, Orange Accountable Care of South Florida, LLC or Orange Accountable Care Organization of South Florida, LLC (collectively
known as “ACO”).
It
is the understanding of the parties to this Letter that the products and services which Manager will provide to providers, practices
and physicians that are members of the ACO (“ACO Participants”) will support the ACO’s mission of Advancing
Care Information in connection with the provision of healthcare services by such ACO Participants to their patients who are Medicare
beneficiaries
The
term of this Letter of intent shall not be less than five months and at the end of such five-month
period, an option
to renew for a term of not less than one (1)year.
Compensation
for the Services provided by Medical Innovation Holdings, Inc. (“MIHI”) pursuant to this Agreement is according to
the following schedule:
|
●
|
A
fifty thousand dollar ($50,000.00) set up fee will be paid to MIHI by Orange Care Group upon signing of this Agreement by
Orange Care Group. Such fee shall be usedby MIHI to initiate performance of the services listed in ExhibitA.
|
|
|
|
|
●
|
Medical
Innovation Holdings, Inc.(“MIHI”) shall charge ACO providers, practices and physicians who elect to purchase any
of the products and services being provided by MIHI a twenty percent (20%) service fee on a cost plus basis of Fair Market
Value for any fee for service. This fee will be subject to negotiation by MIHI with Orange Care Group, its providers, practices
andphysicians.
|
The
above description of the Letter of Intent is intended as a summary only and is qualified in its entirety by the terms and conditions
set forth therein, and may not contain all information that is of interest to the reader. For further information regarding the
terms and conditions of the Letter of Intent, this reference is made to the Letter of Intent, which is filed hereto as Exhibit
10.1 and is incorporated herein by this reference.
SECTION
9 — FINANCIAL STATEMENTS AND EXHIBITS
ITEM9.01
FINANCIAL STATEMENTS AND EXHIBITS
The
following is a complete list of exhibits filed as part of this Report.
Exhibit
numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
Exhibit
No.
|
|
Description
|
10.1
|
|
Letter
of Intent Orange Care Group
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Innovation Holdings, Inc.
|
|
|
|
By
|
/s/
Arturo Jake Sanchez
|
|
Name:
|
Arturo
“Jake” Sanchez
|
|
Title:
|
CEO
|
Date: August 11, 2017